DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

BACKGROUND: Sequential chemo-radiotherapies with intensive radiation components deliver promising results in non-resected non-small cell lung cancer (NSCLC). In general, radiation doses are determined by dose constraints for normal tissues, not by features relevant for tumor control. DART-bid target...

Descripción completa

Detalles Bibliográficos
Autores principales: Wurstbauer, Karl, Deutschmann, Heinz, Dagn, Karin, Kopp, Peter, Zehentmayr, Franz, Lamprecht, Bernd, Porsch, Peter, Wegleitner, Birgit, Studnicka, Michael, Sedlmayer, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606417/
https://www.ncbi.nlm.nih.gov/pubmed/23497555
http://dx.doi.org/10.1186/1748-717X-8-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606417/
https://www.ncbi.nlm.nih.gov/pubmed/23497555
http://dx.doi.org/10.1186/1748-717X-8-49

Ejemplares similares